18 results
424B5
ESPR
Esperion Therapeutics Inc.
22 Jan 24
Prospectus supplement for primary offering
6:04am
patent applications, issued patents or other proprietary rights;
the recruitment or departure of key personnel;
the level of expenses related to any
424B5
ESPR
Esperion Therapeutics Inc.
18 Jan 24
Prospectus supplement for primary offering
4:01pm
;
developments or disputes concerning patent applications, issued patents or other proprietary rights;
the recruitment or departure of key personnel
424B5
ESPR
Esperion Therapeutics Inc.
6 Dec 21
Prospectus supplement for primary offering
4:37pm
patents or other proprietary rights;
the recruitment or departure of key personnel;
S-6
the extent to which we in-license, acquire or invest in other
424B5
mr07yxyu97o6dkz
2 Dec 21
Prospectus supplement for primary offering
5:22pm
424B5
kpl rig30
16 Oct 14
Prospectus supplement for primary offering
12:00am
424B5
1z9mtp56ai4bzs
14 Oct 14
Prospectus supplement for primary offering
12:00am
10-K
bsrn77ksy4wxuct3
13 Mar 14
Annual report
12:00am
10-Q
nkgiv71p3oy0kdfao
12 Aug 13
Quarterly report
12:00am
424B4
n2fofp 58ua3
26 Jun 13
Prospectus supplement with pricing info
12:00am
S-1/A
eju0ek0m fx9m
7 Jun 13
IPO registration (amended)
12:00am
DRS
8v3izqr6b57
12 Apr 13
Draft registration statement
12:00am
- Prev
- 1
- Next